Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Palisade Bio, Inc. Common Stock (PALI)

Biological Products, (no Disgnostic Substances)

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/28/2021

Market Cap

4,548,442

Shares Outstanding

9,270,000

Weighted SO

9,270,894

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

ZURA --.--%

CYTO --.--%

IMMX --.--%

ENVB --.--%

EFTR --.--%

VIRI --.--%

NAVB --.--%

ZVSA --.--%

PHIO --.--%

Beta

1.2990

Last Div

0.0000

Range

3.3-28.95

Chg

0.1800

Avg Vol

69212

Mkt Cap

4548442

Exch

NASDAQ

Country

US

Phone

858 704 4900

DCF Diff

-6.3177

DCF

13.6077

Div Yield

0.0000

P/S

-18.1938

EV Multiple

0.4215

P/FV

0.0047

Div Yield %

0.0000

P/E

-0.0033

PEG

0.0000

Payout

0.0000

Current Ratio

4.3149

Quick Ratio

4.3149

Cash Ratio

4.0032

DSO

-186.8800

DIO

0.0000

Op Cycle

-186.8800

DPO

3291.4035

CCC

-3478.2835

Gross Margin

1.2280

Op Margin

59.8120

Pretax Margin

56.6960

Net Margin

56.6960

Eff Tax Rate

0.0054

ROA

-1.1012

ROE

-1.2486

ROCE

-1.4901

NI/EBT

1.0000

EBT/EBIT

0.9479

EBIT/Rev

59.8120

Debt Ratio

0.0391

D/E

0.0506

LT Debt/Cap

0.0024

Total Debt/Cap

0.0481

Int Coverage

2990.6000

CF/Debt

-24.0298

Equity Multi

1.2937

Rec Turnover

-1.9531

Pay Turnover

0.1109

Inv Turnover

0.0000

FA Turnover

-1.7123

Asset Turnover

-0.0194

OCF/Share

-983.9629

FCF/Share

-983.9629

Cash/Share

924.2104

OCF/Sales

48.3480

FCF/OCF

1.0000

CF Coverage

-24.0298

ST Coverage

-25.2338

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.0047

P/B

0.0047

P/S

-18.1938

P/E

-0.0033

P/FCF

-0.3763

P/OCF

-0.0039

P/CF

-0.0039

PEG

0.0000

P/S

-18.1938

EV Multiple

0.4215

P/FV

0.0047

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 10, 08:05 Palisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook

Revenue Product Segmentation